International Clinical Trial: Construction and preliminary validation of a prediction model for anti-tuberculosis drug concentration in spinal tuberculosis lesions based on sclerotic bone classification

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128514) titled 'Construction and preliminary validation of a prediction model for anti-tuberculosis drug concentration in spinal tuberculosis lesions based on sclerotic bone classification' on July 21.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University

Condition: Spinal tuberculosis

Intervention: Non-sclerotic bone group:None Fragmented sclerotic bone group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: Non-sclerotic bone group:12;Fragmented sclerotic bone group:12;Non-f...